PostersISBT2006PostersTOPIC 01.1The posters areon display fromMonday - ThursdayTOPIC 01.168Topic 01.1.<strong>Blood</strong> Safety - TTD - HIVP-001 IMPLEMENTATION OF HIV P24 ANTIGEN AND ANTIBODY COMBINEDSCREENING ASSAYS IN BLOOD TRANSFUSION INSTITUTE NOVI SADS. Bogdanovic, N. Bujandric, M. Krga-Milanovic (<strong>Blood</strong> <strong>Transfusion</strong> Institute Novi Sad,Novi Sad, Serbia and Montenegro)P-002 USING THE HARMONIC MEAN TO ESTIMATE BLOOD DONORSRECENTLY INFECTED BY HIV AND TO CALCULATE THE RISK THEYPOSE TO THE SOUTH AFRICAN BLOOD SUPPLYG.C. Buckle, G.L. Webb (N.A., Pennington, South Africa)P-003 HTLV I/II INFECTION IN BLOOD DONORS: SEROPREVALENCEAND PERFORMANCE OF DIFFERENT KITSA.O. Chiera, G. Larranaga, C. Bonacina, N. Etchenique (Hemotherapy Institute of BuenosAires Pr, La Plata. Provincia De Buenos Aires, Argentina)P-004 PATTERNS OF BLOOD PRODUCT TRANSFUSIONAT A TERTIARY GYNAECOLOGY UNITF. Botha, J. Nvdlovu, G. Dreyer (Altana Madaus, Woodmead, South Africa)P-005 SURVEILLANCE OF TRANSFUSION TRANSMITTEDINFECTION IN FIRST TIME BLOOD DONORSV. Durro, A. Abazaj, S. Spahiu, S. Seferi (NBTSA, Tirana, Albania)P-006 BLOOD DONORING, PROGRESS IN THE TESTING ON HIV VIRUSC. Gavrancic, B. Gavrancic, T. Jakica (<strong>Blood</strong> <strong>Transfusion</strong> Institute, Novi Sad, Yugoslavia)P-009 TRENDS IN INCIDENCE OF MAJOR TRANSFUSION TRANSMISSIBLEVIRAL INFECTION IN FARS BLOOD DONORS FROM 2002 TILL END OF 2006L. Kasraian, A. Torab Jahromi, B. Farahangiz, A. Torab Jahromi, B. Farahangiz(Ibto Research Center, Shiraz, Iran)P-010 A SURVEY OF EPIDEMIOLOGICAL STATUS AND PREVALENCE RATEOF HIV CASES IN BLOOD DONORS DURING 2005 IN SHIRAZ BLOODTRANSFUSION ORGANIZATIONL. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran)P-011 RISK BEHAVIOR AMONG BLOOD DONORS WHO GIVE BLOOD INORDER TO BE TESTED FOR HIV IN SHIRAZ BLOOD TRANSFUSION IN 2005L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran)P-012 REDUCING THE RISK OF BLOOD BORNE TRANSMISSION HBS, HCVAND HIV THROUGH BLOOD TRANSFUSION BY DONOR SELF-DEFERRALL. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran)P-013 THE TRANSFORMATION OF THE BOTSWANA NATIONAL BLOODTRANSFUSION SERVICEM.K.A. Kayembe, C. Pule, C.I. Tema, J. van Hasselt, S.M. Gaolekwe, B. Gibbs(National Health Laboratory, Gaborone, Botswana)P-014 PREVALENCE OF BLOOD BORNE DISEASE MARKERS ANDRESIDUAL RISK IN BLOOD DONORS AT CROATIAN INSTITUTE OFTRANSFUSION MEDICINE 1995-2005L.M. Lovric, I. Mihaljevic, K. Strahija Tomic, B.M. Balija, J.I. Jukic (Croatian Institute of<strong>Transfusion</strong> Medici, Zagreb, Croatia)69P-007 THE PREVALENCE OF HUMAN HERPESVIRUS 8 (HHV-8)AMONG TEHRAN BLOOD DONORS, HAEMODIALYSIS PATIENTS,AND HIV POSITIVE INDIVIDUALSA. Gharehbaghian, A. Zaghal, M. Farhadi Langerudi, S. Sadri (The Research Center of IBTO,Tehran, Iran)P-008 COST-EFFECTIVENESS OF HIV SCREENINGOF BLOOD DONATIONS IN GHANAM. van Hulst, K.W.C. Sagoe, J.E. Vermande, W.P.A. Van der Tuuk Adriani, E.K. Torpey, J. Ansah,J.A. Mingle, C.Th. Smit Sibinga, M.J. Postma (GUIDE/Martini Hospital, Groningen, Netherlands)P-015 A REVIEW OF BLOOD DONOR RISK MODEL IN ZIMBABWET. Mapako, A. Mvere (National <strong>Blood</strong> Service Zimbabwe, Harare, Zimbabwe)P-016 AN ANALYSIS OF HIV RISK FACTORS FROM POST-DONATIONCOUNSELLING RECORDST. Mapako, S. Shamu, A. Mvere, J. Parirewa (National <strong>Blood</strong> Service Zimbabwe, Harare, Zimbabwe)P-017 HIV-1 INCIDENCE IN BLOOD DONORS IN FRANCE BETWEEN 1992AND 2004: USE OF AN IMMUNOASSAY TO IDENTIFY RECENT INFECTIONSJ.P. Pillonel, F. Barin, S. Laperche, P. Bernillon, S. le Vu, B. Liandier, G. Andreu,J.C. Desenclos (Institut de Veille Sanitaire, Saint-Maurice, France)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
PostersISBT2006PostersTOPIC 01.1TOPIC 01.2The posters areon display fromMonday - ThursdayP-018 DETECTION OF HIV-1 INFECTION IN BLOOD DONORS DURINGTHE IMMUNOLOGICAL WINDOW PERIOD BY THE IMPLEMENTATIONOF NUCLEIC ACID AMPLIFICATION TECHNOLOGYTopic 01.2.<strong>Blood</strong> Safety - TTD - HepatitisP.S.P. Scuracchio, A.G. Oliveira Filho, M.M.M. Lemos, M.C.C. Poli, R. Colella, M.M.C. Magri,N.J.F. Cavalcanti, E.C. Sabino, N.A. Salles, D.A.F. Chamone (Banco de Sangue de Sao Paulo,P-025 UTILITY OF SIMULTANEOUS DETECTION OF HEPATITIS C VIRUSANTIGEN AND ANTIBODIES IN HEMODIALYSIS PATIENTS.São Paulo, Brazil)J.C. Alados Arboledas, L. Calbo, S. de Tena, M.D. Lopez, J.L. de Francisco, C. de MiguelP-019 A STATISTICAL DONOR STATUS MODEL THAT MINIMISES THE RISKOF TRANSFUSION-TRANSMITTED HIV IN SOUTH AFRICAJ.P. Swanevelder, A. Heyns, R. Reddy, M.P. Busch (South African National <strong>Blood</strong> Service(Hospital Del Sas De Jerez, Jerez De La Frontera (Cadiz, Spain)P-026 INCIDENCE OF HBSAG, ANTI-HCV, ANTI-HIV ANTIBODIES IN BLOODDONORS IN OHRID MUNICIPALITY-REPUBLIC OF MACEDONIA(SANBS), Roodepoort (Johannesburg), South Africa)A.M. Aleksioska (Medical Center, Ohrid, Macedonia)P-020 COPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS ANDHEPATITIS B VIRUS AMONG VOLUNTEER BLOOD DONORSP-029 EPIDEMIOLOGICAL INVESTIGATION OF TRANSFUSIONTRANSMISSIBLE INFECTIONS IN BULGARIA70B. Tiwari, P. Ghimire (Central <strong>Blood</strong> <strong>Transfusion</strong> Service, Kathmandu, Nepal)P-021 DOES A HIGH RESULT FOR A QUALITY CONTROL SAMPLE INDICATEA HIGHER FALSE REACTOR RATE IN THE ABBOTT PRISM ASSAYS USEDFOR BLOOD DONOR SCREENING?S. Bakalova, P. Kirova, A. Slivov (National Center of Hematology and <strong>Transfusion</strong>, Sofia, Bulgaria)P-030 THE ELEVATED ALANINE AMINOTRANSFERASE ANDHEPATITIS IN BLOOD DONORSE. Berberi, N. Borici, I. Seferi (National <strong>Blood</strong> <strong>Transfusion</strong> Centre, Tirana, Albania)71S.K. Walker, B. Francis, K. Smeh, S. Ismay, E.M. Dax, M. Karakaltsas (National SerologyReference Laboratory, Fitzroy, Australia)P-022 TRENDS IN INCIDENCE AND PREVALENCE OF MAJOR TRANSFUSION-TRANSMISSIBLE VIRAL INFECTIONS IN UKRAINIAN BLOOD DONORSP-031 HEPATITIS B IN BLOOD DONORS: ANALYSIS OF TESTING RESULTSIN THE PERIOD 2000-2005 IN BLOOD TRANSFUSION INSTITUTE NOVI SADB.N. Bujandric, B.S. Bogdanovic, M. Krga-Milanovic (<strong>Blood</strong> <strong>Transfusion</strong> Institute Novi Sad,Novi Sad, Serbia and Montenegro)M. Zadorin (Clinical research Institute, Kiev, Ukraine)P-023 C-REACTIVE PROTEIN IN HIV POSITIVE SUBJECTSF. Tarabadi, M. Mostakhdemi, M. Shaeigan, G. Babaei, M. Aghaeepour (Iranian <strong>Blood</strong>P-032 BENEFITS OF HCV ANTIGEN/ANTIBODY TESTING; A COMPARISONOF THE NEW ABBOTT MUREX HCV AG/AB COMBINATION ASSAY WITHANTIBODY ONLY TESTING AND A COMPETITOR HCV COMBINATION ASSAY<strong>Transfusion</strong> Organization R, Tehran, Iran)J. Burch, B. Rodgers, J. James, N. Napier, E. Furze, H. Trencher, S. Blincko, D. Trotter,P-024 SOME HEMATOLOGICAL PARAMETERS IN HIV-AIDSPATIENTS IN ILE-IFE, NIGERIAA.O. Adeloye, M.A. Durosinmi (Obafemi Awolowo University, Ile-ife, Nigeria)L. McBryne (Abbott Murex, Dart<strong>for</strong>d, Kent, United Kingdom)P-033 HEPATITIS B VIRUS GENOTYPES, CORE PROMOTER AND PRE-COREMUTATIONS IN SCOTTISH BLOOD DONORSF. Davidson, C. Lycett, E. Erwin, J. Petrik, B. Dow (Scottish National <strong>Blood</strong> <strong>Transfusion</strong> Serv,Edinburgh, United Kingdom)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
- Page 24 and 25: XXIX th International Congressof th
- Page 26 and 27: ISBT2006WORDS OF WELCOME5It is with
- Page 28 and 29: ISBT20068ORGANISATION - COMMITTEESO
- Page 30 and 31: Programme per DayISBT2006Programme
- Page 32 and 33: ISBT2006Programme per DayTHURSDAY,
- Page 34 and 35: Sunday, 3 SeptemberISBT2006Sunday,
- Page 36 and 37: Sunday, 3 SeptemberISBT2006Monday,
- Page 38 and 39: Monday, 4 SeptemberISBT2006Monday,
- Page 40 and 41: Monday, 4 SeptemberISBT2006Monday,
- Page 42 and 43: Monday, 4 SeptemberISBT2006Monday,
- Page 44 and 45: Monday, 4 SeptemberISBT2006Tuesday,
- Page 46 and 47: Tuesday, September 5ISBT2006Wednesd
- Page 48 and 49: Wednesday, 6 SeptemberISBT2006Wedne
- Page 50 and 51: Wednesday, 6 SeptemberISBT2006Wedne
- Page 52 and 53: Wednesday, 6 SeptemberISBT2006Wedne
- Page 54 and 55: Wednesday, 6 SeptemberISBT2006Thurs
- Page 56 and 57: Thursday, 7 SeptemberISBT2006Thursd
- Page 60 and 61: PostersISBT2006PostersTOPIC 01.2TOP
- Page 62 and 63: PostersISBT2006PostersTOPIC 01.2TOP
- Page 64 and 65: PostersISBT2006PostersTOPIC 01.5The
- Page 66 and 67: PostersISBT2006PostersTOPIC 01.6TOP
- Page 68 and 69: PostersISBT2006PostersTOPIC 01.8The
- Page 70 and 71: PostersISBT2006PostersTOPIC 02.1TOP
- Page 72 and 73: PostersISBT2006PostersTOPIC 02.1TOP
- Page 74 and 75: PostersISBT2006PostersTOPIC 02.1TOP
- Page 76 and 77: PostersISBT2006PostersTOPIC 02.2TOP
- Page 78 and 79: PostersISBT2006PostersTOPIC 02.4TOP
- Page 80 and 81: PostersISBT2006PostersTOPIC 03.2The
- Page 82 and 83: PostersISBT2006PostersTOPIC 04.3The
- Page 84 and 85: PostersISBT2006PostersTOPIC 05.2The
- Page 86 and 87: PostersISBT2006PostersTOPIC 05.2TOP
- Page 88 and 89: PostersISBT2006PostersTOPIC 07.2The
- Page 90 and 91: PostersISBT2006PostersTOPIC 08.1-3T
- Page 92 and 93: PostersISBT2006PostersTOPIC 09.2TOP
- Page 94 and 95: PostersISBT2006PostersTOPIC 10.1TOP
- Page 96 and 97: PostersISBT2006PostersTOPIC 11.1The
- Page 98 and 99: PostersISBT2006PostersTOPIC 11.4The
- Page 100 and 101: PostersISBT2006PostersTOPIC 13.0TOP
- Page 102 and 103: PostersISBT2006PostersTOPIC 15.0TOP
- Page 104 and 105: ISBT Business MeetingsISBT2006Key I
- Page 106 and 107: Key InformationISBT2006Key Informat
- Page 108 and 109:
Scientific InformationISBT2006Scien
- Page 110 and 111:
Registration InformationISBT2006Soc
- Page 112 and 113:
ISBT2006FLOORPLANGROUND FLOORFLOORP
- Page 114 and 115:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 116 and 117:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 118 and 119:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 120 and 121:
ISBT2006LIST OF EXHIBITORSin terms
- Page 122 and 123:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 124 and 125:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 126 and 127:
ISBT2006LIST OF EXHIBITORS59 Cape C
- Page 128 and 129:
ISBT2006MAP OF CAPE TOWNSPEAKERS IN
- Page 130 and 131:
International Society ofBlood Trans
- Page 132:
ISBT2006NOTES216INTERNATIONAL SOCIE